These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 12747791

  • 1. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors.
    Winum JY, Vullo D, Casini A, Montero JL, Scozzafava A, Supuran CT.
    J Med Chem; 2003 May 22; 46(11):2197-204. PubMed ID: 12747791
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates.
    Winum JY, Pastorekova S, Jakubickova L, Montero JL, Scozzafava A, Pastorek J, Vullo D, Innocenti A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Feb 01; 15(3):579-84. PubMed ID: 15664816
    [Abstract] [Full Text] [Related]

  • 4. Carbonic anhydrase inhibitors; fluorinated phenyl sulfamates show strong inhibitory activity and selectivity for the inhibition of the tumor-associated isozymes IX and XII over the cytosolic ones I and II.
    Winum JY, Innocenti A, Vullo D, Montero JL, Supuran CT.
    Bioorg Med Chem Lett; 2009 Sep 01; 19(17):5082-5. PubMed ID: 19632111
    [Abstract] [Full Text] [Related]

  • 5. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L, Fasolis G, Vullo D, Chohan ZH, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3096-101. PubMed ID: 15908204
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives.
    Ilies MA, Vullo D, Pastorek J, Scozzafava A, Ilies M, Caproiu MT, Pastorekova S, Supuran CT.
    J Med Chem; 2003 May 22; 46(11):2187-96. PubMed ID: 12747790
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sulfamates and their therapeutic potential.
    Winum JY, Scozzafava A, Montero JL, Supuran CT.
    Med Res Rev; 2005 Mar 22; 25(2):186-228. PubMed ID: 15478125
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Puccetti L, Fasolis G, Cecchi A, Winum JY, Gamberi A, Montero JL, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2359-64. PubMed ID: 15837325
    [Abstract] [Full Text] [Related]

  • 13. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B, Sławiński J, Pogorzelska A, Chojnacki J, Vullo D, Supuran CT.
    Eur J Med Chem; 2014 Jan 02; 71():135-47. PubMed ID: 24291567
    [Abstract] [Full Text] [Related]

  • 14. Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
    Cecchi A, Taylor SD, Liu Y, Hill B, Vullo D, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Dec 01; 15(23):5192-6. PubMed ID: 16203142
    [Abstract] [Full Text] [Related]

  • 15. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
    Winum JY, Dogné JM, Casini A, de Leval X, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.
    J Med Chem; 2005 Mar 24; 48(6):2121-5. PubMed ID: 15771455
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
    Cecchi A, Winum JY, Innocenti A, Vullo D, Montero JL, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2004 Dec 06; 14(23):5775-80. PubMed ID: 15501039
    [Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with benzo[b]thiophene 1,1-dioxide sulfonamides.
    Innocenti A, Villar R, Martinez-Merino V, Gil MJ, Scozzafava A, Vullo D, Supuran CT.
    Bioorg Med Chem Lett; 2005 Nov 01; 15(21):4872-6. PubMed ID: 16165351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.